Wen, Xuerong http://orcid.org/0000-0002-4803-7895
Wang, Shuang
Lewkowitz, Adam K.
Ward, Kristina E.
Brousseau, Erin Christine
Meador, Kimford J.
Funding for this research was provided by:
National Institute of Child Health and Human Development (1R15HD097588-01)
Article History
Accepted: 15 August 2021
First Online: 5 October 2021
Declarations
:
: The study is funded by grants from the National Institute of Health (NIH)/National Institute of Child Health and Human Development (NIH/NICHD Grant number: 1R15HD097588-01; Principal Investigator: Xuerong Wen). The funding source had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
: Dr Meador has received research support from the National Institutes of Health and Sunovion Pharmaceuticals, and travel support from UCB Pharma. The Epilepsy Study Consortium pays Dr Meador’s university for his research consultant time related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, and UCB Pharma. Other authors, XW, SW, AKL, KEW, and ECB have no conflicts of interests to declare.
: The study data was linked and deidentified by the RI DOH and RI EOHHS. The deidentified data was released to Dr Wen’s research team as per the Data Utilization Agreement.
: Not applicable.
: This study was considered exempt by the RI DOH IRB and URI IRB.
: Not applicable.
: Not applicable.
: Dr Xuerong had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: Wen, Meador, Wang. Acquisition, analysis, or interpretation of data: Wen, Wang. Drafting of the manuscript: Wen, Wang, Meador, Lewkowitz. Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Wang. Clinical, technical, or material support: Lewkowitz, Ward, Brousseau. Supervision: Wen, Meador. All authors read and approved the final version.